secwatch.observer — SEC 8-K summary
======================================

Issuer:     Beyond Air, Inc. (XAIR)
CIK:        0001641631
Form:       8-K
Filed at:   2026-01-15T23:59:59+00:00
Accession:  0001493152-26-002292
Event type: m_and_a
Sentiment:  positive
Materiality: 0.75
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

XTL to acquire 85% of Beyond Air's NeuroNOS for equity, $1M cash, up to $32.5M milestones
--------------------------------------------------------------------------------

- XTL acquires 85% of NeuroNOS for 19.9% of XTL's share capital, $1M cash, and up to $32.5M in milestone payments.
- NeuroNOS platform targets core autism pathophysiology; two Nobel Laureates join scientific team.
- NeuroNOS holds two FDA Orphan Drug Designations for Phelan-McDermid Syndrome and Glioblastoma.
- Beyond Air becomes significant XTL shareholder, retains 15% of NeuroNOS; deal valued up to $32.5M.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1641631/000149315226002292/0001493152-26-002292-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1641631/000149315226002292/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-26-002292

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer